- Home
- / Ipca Laboratories
Ipca Laboratories
Stock Price
₹1.6 K
2024-10-29
Market Capitalization
₹400.9 B
2024-10-29
Revenue
₹88.5 B
FY, 2025
Ipca Laboratories Summary
Company Summary
- Overview
- Ipca Laboratories is a pharmaceutical company. It produces and markets drug intermediates and APIs (active pharmaceutical ingredients) for rheumatology, gastrointestinal, cardiovascular, dermatology, urology, and ophthalmology disorders.
- Type
- Public
- Status
- Active
- Founded
- 1949
- HQ
- Mumbai, IN | view all locations
- Website
- https://ipca.com/
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
Key People
Pranay Godha, Executive Director
Prashant Godha, Executive Director
Anand T. Kusre, Director
LocationsView all
10 locations detected
Mumbai, MH HQ
India
125, Kandivli Industrial Estate, Kandivli
Ankleshwar, GJ
India
Plot No. 4722, 4723 & 4731 G.I.D.C. Estate
Aurangabad, MH
India
H-4, MIDC Industrial Area, Waluj
Boisar, MH
India
E-41 & E-129, MIDC Tarapur, Boisar
Indore, MP
India
89a/b, 90, 91 industrial estate
Mumbai, MH
India
48, Kandivli Industrial Estate Kandivli
Ipca Laboratories Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹23.9B
- Gross profit (Q3, 2026)
- ₹17.5B
- Net income (Q3, 2026)
- ₹3.6B
- Cash (Q2, 2026)
- ₹2.6B
- EBIT (Q3, 2026)
- ₹4.6B
- Enterprise value
- $411.0B